Servicios Personalizados
Revista
Articulo
Artículo en XML
Referencias del artículo
Traducción automática
Enviar artículo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Similares en
SciELO
Compartir
Permalink
Revista médica del Hospital General de México
versión On-line ISSN 2524-177Xversión impresa ISSN 0185-1063
Resumen
MIGDAN, Carmen M. y LERMA-PUERTAS, Diego. Perinatal morbidity in gestations with pathological combined first trimester screening for aneuploidies and normal karyotype. Rev. med. Hosp. Gen. Méx. [online]. 2022, vol.85, n.3, pp.114-119. Epub 07-Oct-2022. ISSN 2524-177X. https://doi.org/10.24875/hgmx.21000096.
Objective:
Positive Combined First Trimester Screening and by risk groups: 0-50, 51-100, 101-150, 151-200, 201-250, and normal karyotype relate with negative screening for adverse perinatal results.
Method:
Retrospective study of cases and controls in single pregnancies, with predictive analysis using multivariate logistic regression.
Results:
3,791 screenings were performed at our unit in 2012, with a screening/number of deliveries ratio of 89.9%. There is a greater likelihood of the newborn being underweight (AOR = 2.6, 95% CI 1.2 – 5.7), premature (OR = 2.2, 95% CI 1.03 – 4.5), admitted to the ICU (OR = 7.4, CI 95% 1.5 – 34.6) or admitted to the Neonates department (AOR = 8.1, 95% CI 1.7 – 37.7) in the case group.
Conclusion:
Combined first trimester screening is a predictive method for pregnant women with a higher risk of adverse perinatal outcomes.
Palabras llave : PAPP-A; β-HCG; Adverse perinatal outcomes; Aneuploidies.
pdf
)
